Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2020-10-28 Regulatory Filings
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports on material definitive agreements entered into by Novavax, Inc., including a vaccine supply agreement with the UK government and a lease agreement for premises. The document is dated October 22, 2020, and includes detailed descriptions of these agreements. It is not an annual or quarterly report, nor is it an earnings release or a proxy statement. It is a regulatory filing reporting material events outside of regular periodic reports. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 8270 characters, which is substantive and contains detailed information, not just an announcement of a report or a certification.
2020-10-28 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-01 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-01 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-30 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-30 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.